Frailty in inflammatory bowel diseases: an emerging concept

被引:17
|
作者
Kochar, Bharati [1 ,2 ,3 ]
Orkaby, Ariela R. [3 ,4 ,5 ]
Ananthakrishnan, Ashwin N. [2 ,3 ,6 ]
Ritchie, Christine S. [2 ,3 ,7 ]
机构
[1] Massachusetts Gen Hosp, Crohns & Colitis Ctr, Div Gastroenterol, 165 Cambridge St,9th Floor, Boston, MA 02114 USA
[2] Mongan Inst, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] VA Boston Healthcare Syst, New England Geriatr Res Educ & Clin Ctr, Bedford, MA USA
[5] Brigham & Womens Hosp, Div Aging, 75 Francis St, Boston, MA 02115 USA
[6] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
[7] Massachusetts Gen Hosp, Div Palliat Care & Geriatr Med, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
aging; Crohn's disease; frailty; geriatrics; inflammation; inflammatory bowel diseases; ulcerative colitis; OLDER PATIENTS; ELDERLY-PATIENTS; ULCERATIVE-COLITIS; CORTICOSTEROID USE; CROHNS-DISEASE; MORTALITY; OUTCOMES; CANCER; INDEX; PATIENT;
D O I
10.1177/17562848211025474
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel diseases (IBD), consisting of Crohn's disease and ulcerative colitis, are chronic remitting, relapsing inflammatory conditions of the gastrointestinal tract. While traditionally a disease of younger ages, the number of older adults with IBD is rising rapidly. Patients with IBD often experience geriatric syndromes at earlier ages. Older adults with IBD have poorer disease and treatment-related outcomes compared with younger adults with IBD. Applying the principles of geriatrics to understanding a chronic disease in older adults may improve health span. Better tools are needed to stratify IBD patients who are at high risk for adverse events. Frailty is a geriatric construct that may approximate biologic age. Frailty is a complex, multi-dimensional syndrome that leads to increased vulnerability to stress and decline of reserve across multiple physiologic systems. In this review, we present the leading conceptual models of frailty and discuss the applications of frailty in immune-mediated diseases. We also review chronic conditions where frailty has been applied successfully as a tool for risk stratification. Finally, we discuss in the detail the growing body of literature highlighting the relationship between frailty and IBD, the epidemiology of frailty in IBD, and ramifications of frailty in IBD.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Emerging Therapies for Inflammatory Bowel Diseases
    Khanna, Reena
    Feagan, Brian G.
    [J]. DIGESTIVE DISEASES, 2016, 34 : 67 - 73
  • [2] Emerging pharmacotherapy for inflammatory bowel diseases
    Luo, Hua
    Cao, Guiqing
    Luo, Chun
    Tan, Dechao
    Vong, Chi Teng
    Xu, Yinyue
    Wang, Sicen
    Lu, Haitao
    Wang, Yitao
    Jing, Wanghui
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 178
  • [3] The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases
    Minea, Horia
    Singeap, Ana-Maria
    Minea, Manuela
    Juncu, Simona
    Muzica, Cristina
    Sfarti, Catalin Victor
    Girleanu, Irina
    Chiriac, Stefan
    Miftode, Ioana Diandra
    Stanciu, Carol
    Trifan, Anca
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [4] Emerging biological treatments in inflammatory bowel diseases
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    [J]. DIGESTIVE DISEASES, 2006, 24 (1-2) : 131 - 136
  • [5] New and emerging therapies for inflammatory bowel diseases
    Grimm, Michael C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : S69 - S74
  • [6] Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence
    Neelam, Pardhu B.
    Sharma, Alka
    Sharma, Vishal
    [J]. JGH OPEN, 2024, 8 (01):
  • [7] Role of Emerging Campylobacter Species in Inflammatory Bowel Diseases
    Kaakoush, Nadeem O.
    Mitchell, Hazel M.
    Man, Si Ming
    [J]. INFLAMMATORY BOWEL DISEASES, 2014, 20 (11) : 2189 - 2197
  • [8] Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases
    Caire, M. Thure
    Strauss, Alexandra T.
    Kumar, Ambuj
    Brady, Patrick
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (12) : E46 - E46
  • [9] Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases
    Soubieres, Anet A.
    Poullis, Andrew
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 2016 - 2022
  • [10] Alternative Medicines as Emerging Therapies for Inflammatory Bowel Diseases
    Singh, Udai P.
    Singh, Narendra P.
    Busbee, Brandon
    Guan, H.
    Singh, Balwan
    Price, Robert L.
    Taub, Dennis D.
    Mishra, Manoj K.
    Nagarkatti, Mitzi
    Nagarkatti, Prakash S.
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2012, 31 (01) : 66 - 84